Therapeutic Delivery – Webinars and Online Events

Although the primary focus of the pharmaceutical industry has been identifying the mechanisms of drug elimination and potential drug liability, there is now an increasing focus on the kidney as a therapeutic target.

Join Dr Natalia Sannikova and Tomas Skrinskas from Ascension Sciences, as they explore the therapeutic use of cannabinoids as novel medicines and the opportunities of nanotechnology in formulating cannabinoid nanoparticles.

Lipid nanoparticle (LNP) technology is increasingly enabling the clinical potential of genetic drugs. By packaging the nucleic acid polymer in well-defined nanoparticles, LNPs protect the nucleic acid payload in vivo and facilitate intracellular delivery following uptake into target cells by endocytosis.